Obesity Therapy
Obecure recruits first patient in Phase II obesity study
Published in Medical Letter on the CDC and FDA, February 25th, 2007
The study is a double-blinded, placebo-controlled dose-ranging study in about 280 subjects over a period of three months. The study will be carried out at 20 medical sites across the U.S.
Betahistine is currently marketed in many countries for the treatment of vertigo. The drug was first approved in the mid 1960's but was taken off the U.S. market by the U.S. Food & Drug Administration for lack of clinical evidence in that indication. Notably, no safety issues were raised and a recent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Neurourology
Studies from University of California, Department of Urology yield new data on neurourology - Accreditation
Humana Military Healthcare Services receives URAC HIPAA Privacy Accreditation - Addiction Medicine
Ortho-Clinical Diagnostics offers complete drugs-of-abuse panel, adds five assays - Business Update
Aethlon Medical signs government research alliance - Business Update
CytoCore ready to manufacture e2 Collector - Business Update
Generic Medical Devices receives 510(k) clearance for GMD Universal Circumcision Clamp - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
